Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From bone replacement to regeneration. A biomaterials started journey.

Materials today. Bio·2026
Same author

New materials and complications of prostheses in humans: situation in Spain.

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia·2024
Same author

A novel hybrid nanofibrous strategy to target progenitor cells for cost-effective in situ angiogenesis.

Journal of materials chemistry. B·2020
Same author

Towards 4th generation biomaterials: a covalent hybrid polymer-ormoglass architecture.

Nanoscale·2015
Same author

The relevance of biomaterials to the prevention and treatment of osteoporosis.

Acta biomaterialia·2014
Same author

Bioactivation of calcium deficient hydroxyapatite with foamed gelatin gel. A new injectable self-setting bone analogue.

Journal of materials science. Materials in medicine·2013

Related Experiment Video

Updated: Jul 3, 2026

Biological Compatibility Profile on Biomaterials for Bone Regeneration
10:28

Biological Compatibility Profile on Biomaterials for Bone Regeneration

Published on: November 16, 2018

Biomaterials in orthopaedics.

M Navarro1, A Michiardi, O Castaño

  • 1Biomaterials, Implants and Tissue Engineering, Institute for Bioengineering of Catalonia (IBEC), CIBER-BBN, 08028 Barcelona, Spain. mnavarro@ibec.pcb.ub.es

Journal of the Royal Society, Interface
|August 1, 2008
PubMed
Summary

Orthopaedic biomaterials have evolved over 50 years through three generations, from bioinert to bioactive and now molecularly targeted materials, addressing unmet needs in bone and joint repair.

More Related Videos

Decellularized Apple-Derived Scaffolds for Bone Tissue Engineering In Vitro and In Vivo
09:49

Decellularized Apple-Derived Scaffolds for Bone Tissue Engineering In Vitro and In Vivo

Published on: February 23, 2024

Direct and Indirect Culture Methods for Studying Biodegradable Implant Materials In Vitro
14:49

Direct and Indirect Culture Methods for Studying Biodegradable Implant Materials In Vitro

Published on: April 15, 2022

Related Experiment Videos

Last Updated: Jul 3, 2026

Biological Compatibility Profile on Biomaterials for Bone Regeneration
10:28

Biological Compatibility Profile on Biomaterials for Bone Regeneration

Published on: November 16, 2018

Decellularized Apple-Derived Scaffolds for Bone Tissue Engineering In Vitro and In Vivo
09:49

Decellularized Apple-Derived Scaffolds for Bone Tissue Engineering In Vitro and In Vivo

Published on: February 23, 2024

Direct and Indirect Culture Methods for Studying Biodegradable Implant Materials In Vitro
14:49

Direct and Indirect Culture Methods for Studying Biodegradable Implant Materials In Vitro

Published on: April 15, 2022

Area of Science:

  • Biomaterials Science
  • Orthopaedics
  • Regenerative Medicine

Background:

  • Significant unmet needs persist in orthopaedics for bone and joint substitution and defect repair.
  • The field of biomaterials has seen substantial advancements over the past 50 years.

Purpose of the Study:

  • To review the evolution of biomaterials used in orthopaedic applications.
  • To discuss different materials and approaches for addressing orthopaedic challenges.

Main Methods:

  • Review of literature on biomaterials in orthopaedics.
  • Analysis of the progression through three generations of biomaterials: bioinert, bioactive/biodegradable, and molecularly targeted.

Main Results:

  • Biomaterials have progressed from bioinert (1st gen) to bioactive and biodegradable (2nd gen).
  • Current third-generation biomaterials are designed for specific molecular-level interactions.
  • Metals, ceramics, and polymers are key materials discussed in their orthopaedic evolution.

Conclusions:

  • The evolution of biomaterials offers promising solutions for current orthopaedic demands.
  • Continued innovation in biomaterials is crucial for advancing bone and joint repair and regeneration.